Clinical Trial

HERO System - Health Monitoring for the Detection of Vital Signs and Emotional States

Study acronym: HERO
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
New technologies offer significant opportunities to enhance the quality and intensity of care services, amplifying the ability to respond to patient needs through contactless solutions that also contribute to the humanization of care. Their application in patient monitoring can enable continuous observation, even in the absence of physically present staff, for a larger number of non-critical patients (thus reducing the risk of adverse events), and facilitate timely interventions when needed-aligned with the logic of Anglo-Saxon models based on Early Warning Systems. The general objective of this study is to conduct a pilot clinical trial of a specific solution based on Artificial Intelligence and Computer Vision, the HERO Health Monitoring (HHM) system, capable of detecting vital signs (heart rate, respiratory rate, blood oxygen saturation, and blood pressure), body posture, movements, and patients' emotional states-such as expressions of pain-using simple video devices. The study aims, in particular, to measure the concordance of the system's vital sign measurements with standard (telemetric) systems, and to assess the added value of combining these measurements with the additional information provided by HHM regarding posture, movement, and emotional state analysis-once their agreement has been verified against patient-reported outcomes collected via self-assessment questionnaires. This is an observational study involving the HERO Health Monitoring medical device, for which the certification process is expected to be completed through the present study.
Trial Details
NCT Number NCT07248969
Lead Sponsor Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions Cardiovascular
Enrollment 100 participants
Start Date 2024-04-01
Primary Completion 2025-08-01 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-11-25